*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>6,7-Dimethoxy-3,4-dihydroisoquinoline hydrochloride hydrate</strong> (CAS: <strong>20232-39-7</strong>) is a key pharmaceutical intermediate synthesized via cyclization of substituted phenethylamines. Its molecular formula serves as a critical scaffold for heterocyclic chemistry in API manufacturing.</p>
<h3>Application</h3>
<ul>
<li>Synthesis of isoquinoline-based alkaloids and central nervous system drugs.</li>
<li>Production of cardiovascular therapeutic agents requiring specific ring structures.</li>
<li>R&D of novel kinase inhibitors utilizing the dihydroisoquinoline core.</li>
</ul>
<h3>Precautions</h3>
<p>Storage requires sealed containers under dry conditions below 25°C to prevent hydration loss. Personnel must wear PPE due to potential irritant properties; avoid inhalation or skin contact during handling.</p>